Literature DB >> 25967354

Radiological Features in Patients with Short Stature Homeobox-Containing (SHOX) Gene Deficiency and Turner Syndrome before and after 2 Years of GH Treatment.

Christopher J Child1, Gabriel Kalifa, Christine Jones, Judith L Ross, Gudrun A Rappold, Charmian A Quigley, Alan G Zimmermann, Gina Garding, Gordon B Cutler, Werner F Blum.   

Abstract

BACKGROUND/AIMS: The short stature homeobox-containing (SHOX) gene is one of many genes that regulate longitudinal growth. The SHOX deficiency (SHOX-D) phenotype, caused by intragenic or regulatory region defects, ranges from normal stature to mesomelic skeletal dysplasia. We investigated differences in radiological anomalies between patients with SHOX-D and Turner syndrome (TS) and the effect of 2 years of growth hormone (GH) treatment on these anomalies.
METHODS: Left hand/wrist, forearm and lower leg radiographs were assessed at baseline and after 2 years in children with genetically confirmed SHOX-D (GH-treated and untreated groups) and TS (GH-treated) in a randomised, controlled, multinational study.
RESULTS: Radiological anomalies of hand, wrist and forearm were common in SHOX-D and TS. Radial bowing appeared more prevalent in SHOX-D, while lower leg anomalies were more common in TS. There were no significant differences in radiological findings between GH-treated and untreated patients with SHOX-D after 2 years.
CONCLUSION: GH treatment had no systematic effect on skeletal findings in SHOX-D, based on limited radiological differences between the GH-treated and untreated groups at 2 years. Bone age radiographs allow assessment of radiological signs indicating a potential diagnosis of SHOX-D and may lead to earlier genetic confirmation and initiation of GH therapy.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25967354     DOI: 10.1159/000381712

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  6 in total

1.  Safety Outcomes and Near-Adult Height Gain of Growth Hormone-Treated Children with SHOX Deficiency: Data from an Observational Study and a Clinical Trial.

Authors:  Imane Benabbad; Myriam Rosilio; Christopher J Child; Jean-Claude Carel; Judith L Ross; Cheri L Deal; Stenvert L S Drop; Alan G Zimmermann; Nan Jia; Charmian A Quigley; Werner F Blum
Journal:  Horm Res Paediatr       Date:  2016-12-22       Impact factor: 2.852

Review 2.  A Track Record on SHOX: From Basic Research to Complex Models and Therapy.

Authors:  Antonio Marchini; Tsutomu Ogata; Gudrun A Rappold
Journal:  Endocr Rev       Date:  2016-06-29       Impact factor: 19.871

3.  Investigation of SHOX Gene Mutations in Turkish Patients with Idiopathic Short Stature.

Authors:  Kenan Delil; Halil Gürhan Karabulut; Bülent Hacıhamdioğlu; Zeynep Şıklar; Merih Berberoğlu; Gönül Öçal; Ajlan Tükün; Hatice Ilgın Ruhi
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-12-18

4.  Short Stature Homeobox-Containing Haploinsufficiency in Seven Siblings with Short Stature.

Authors:  Elizabeth S Sandberg; Ali S Calikoglu; Karen J Loechner; Lydia L Snyder
Journal:  Case Rep Endocrinol       Date:  2017-08-30

5.  Origin of the X-chromosome influences the development and treatment outcomes of Turner syndrome.

Authors:  Ying Zhang; Yongchen Yang; Pin Li; Sheng Guo
Journal:  PeerJ       Date:  2021-12-09       Impact factor: 2.984

Review 6.  Factors affecting prepubertal and pubertal bone age progression.

Authors:  Mari Satoh; Yukihiro Hasegawa
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-22       Impact factor: 6.055

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.